Status of long absentees among multibacillary leprosy patients admitted to a controlled clinical study

Indian Journal of Leprosy

Volumn 72, Issue 4, 2000, Pages 469-475

  Jaggarajamma, K ^a   Thomas, A ^a   Nagarajan, M ^a  

^a NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CLOFAZIMINE; DAPSONE; ISONIAZID; RIFAMPICIN;

ARTICLE; BACTERIOLOGY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DRUG EFFICACY; HEALTH STATUS; HOME CARE; HOSPITAL ADMISSION; HUMAN; LEPROSY; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

DRUG THERAPY, COMBINATION; HUMANS; LEPROSTATIC AGENTS; LEPROSY; PATIENT COMPLIANCE; PATIENT DROPOUTS;

EID: 0034493823     PISSN: 02549395     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. A case of relapse with drug susceptible M. leprae after multidrug therapy
2. Clinical and bacteriological progress of highly bacillated BL-LL patients discontinuing treatment after different periods of MDT
3. The pattern of "Drop-outs" of smear-positive cases at an urban leprosy centre
4. Non-compliance among leprosy patients
5. Discussion on criteria for assessment of drug activity
6. A retrospective study of "Non-compliant" patients in controlled clinical trials of short-course chemotherapy
7. Controlled clinical trial of two multidrug regimens with and without rifampicin in highly bacilliferous BL/LL south Indian patients. A five-year report
8. Relapses during long-term follow-up with drug susceptible M. leprae among multibacillary leprosy patients treated with multidrug therapy regimens, case reports
9. Chemotherapy of leprosy for control programmes
10. WHO Committee on leprosy. Sixth Report